183 related articles for article (PubMed ID: 28211453)
41. Structures of the ligand-binding core of iGluR2 in complex with the agonists (R)- and (S)-2-amino-3-(4-hydroxy-1,2,5-thiadiazol-3-yl)propionic acid explain their unusual equipotency.
Beich-Frandsen M; Pickering DS; Mirza O; Johansen TN; Greenwood J; Vestergaard B; Schousboe A; Gajhede M; Liljefors T; Kastrup JS
J Med Chem; 2008 Mar; 51(5):1459-63. PubMed ID: 18269227
[TBL] [Abstract][Full Text] [Related]
42. Structure of an agonist-bound ionotropic glutamate receptor.
Yelshanskaya MV; Li M; Sobolevsky AI
Science; 2014 Aug; 345(6200):1070-4. PubMed ID: 25103407
[TBL] [Abstract][Full Text] [Related]
43. Characterization of the pharmacology and regional distribution of (S)-[3H]-5-fluorowillardiine binding in rat brain.
Hawkins LM; Beaver KM; Jane DE; Taylor PM; Sunter DC; Roberts PJ
Br J Pharmacol; 1995 Oct; 116(3):2033-9. PubMed ID: 8640342
[TBL] [Abstract][Full Text] [Related]
44. A molecular envelope of the ligand-binding domain of a glutamate receptor in the presence and absence of agonist.
Abele R; Svergun D; Keinänen K; Koch MH; Madden DR
Biochemistry; 1999 Aug; 38(34):10949-57. PubMed ID: 10460150
[TBL] [Abstract][Full Text] [Related]
45. Characterization of a new AMPA receptor radioligand, [3H]2-amino-3-(3-carboxy-5-methyl-4-isoxazolyl)propionic acid.
Stensbøl TB; Sløk FA; Trometer J; Hurt S; Ebert B; Kjøller C; Egebjerg J; Madsen U; Diemer NH; Krogsgaard-Larsen P
Eur J Pharmacol; 1999 Jun; 373(2-3):251-62. PubMed ID: 10414446
[TBL] [Abstract][Full Text] [Related]
46. A domain linking the AMPA receptor agonist binding site to the ion pore controls gating and causes lurcher properties when mutated.
Schmid SM; Körber C; Herrmann S; Werner M; Hollmann M
J Neurosci; 2007 Nov; 27(45):12230-41. PubMed ID: 17989289
[TBL] [Abstract][Full Text] [Related]
47. Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].
Ebert B; Lenz S; Brehm L; Bregnedal P; Hansen JJ; Frederiksen K; Bøgesø KP; Krogsgaard-Larsen P
J Med Chem; 1994 Apr; 37(7):878-84. PubMed ID: 7512140
[TBL] [Abstract][Full Text] [Related]
48. Heteroaryl analogues of AMPA. 2. Synthesis, absolute stereochemistry, photochemistry, and structure-activity relationships.
Falch E; Brehm L; Mikkelsen I; Johansen TN; Skjaerbaek N; Nielsen B; Stensbøl TB; Ebert B; Krogsgaard-Larsen P
J Med Chem; 1998 Jul; 41(14):2513-23. PubMed ID: 9651156
[TBL] [Abstract][Full Text] [Related]
49. Use of [3H]fluorowillardiine to study properties of AMPA receptor allosteric modulators.
Kessler M; Arai AC
Brain Res; 2006 Mar; 1076(1):25-41. PubMed ID: 16256076
[TBL] [Abstract][Full Text] [Related]
50. AMPA receptor ligand binding domain mobility revealed by functional cross linking.
Plested AJ; Mayer ML
J Neurosci; 2009 Sep; 29(38):11912-23. PubMed ID: 19776277
[TBL] [Abstract][Full Text] [Related]
51. Chemistry and conformation of the ligand-binding domain of GluR2 subtype of glutamate receptors.
Cheng Q; Jayaraman V
J Biol Chem; 2004 Jun; 279(25):26346-50. PubMed ID: 15100219
[TBL] [Abstract][Full Text] [Related]
52. Effects of thiocyanate and AMPA receptor ligands on (S)-5-fluorowillardiine, (S)-AMPA and (R,S)-AMPA binding.
Hawkinson JE; Espitia SA
Eur J Pharmacol; 1997 Jun; 329(2-3):213-21. PubMed ID: 9226415
[TBL] [Abstract][Full Text] [Related]
53. Binding of 5'-GMP to the GluR2 AMPA receptor: insight from targeted molecular dynamics simulations.
Mendieta J; Gago F; Ramírez G
Biochemistry; 2005 Nov; 44(44):14470-6. PubMed ID: 16262247
[TBL] [Abstract][Full Text] [Related]
54. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
Moretti L; Pentikäinen OT; Settimo L; Johnson MS
J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
[TBL] [Abstract][Full Text] [Related]
55. Characterizing single-channel behavior of GluA3 receptors.
Poon K; Nowak LM; Oswald RE
Biophys J; 2010 Sep; 99(5):1437-46. PubMed ID: 20816055
[TBL] [Abstract][Full Text] [Related]
56. Kainate induces various domain closures in AMPA and kainate receptors.
Venskutonytė R; Frydenvang K; Hald H; Rabassa AC; Gajhede M; Ahring PK; Kastrup JS
Neurochem Int; 2012 Sep; 61(4):536-45. PubMed ID: 22425692
[TBL] [Abstract][Full Text] [Related]
57. On the binding determinants of the glutamate agonist with the glutamate receptor ligand binding domain.
Speranskiy K; Kurnikova M
Biochemistry; 2005 Aug; 44(34):11508-17. PubMed ID: 16114887
[TBL] [Abstract][Full Text] [Related]
58. Light-evoked excitatory synaptic currents of X-type retinal ganglion cells.
Cohen ED
J Neurophysiol; 2000 Jun; 83(6):3217-29. PubMed ID: 10848542
[TBL] [Abstract][Full Text] [Related]
59. Structural basis for AMPA receptor activation and ligand selectivity: crystal structures of five agonist complexes with the GluR2 ligand-binding core.
Hogner A; Kastrup JS; Jin R; Liljefors T; Mayer ML; Egebjerg J; Larsen IK; Gouaux E
J Mol Biol; 2002 Sep; 322(1):93-109. PubMed ID: 12215417
[TBL] [Abstract][Full Text] [Related]
60. Excitatory amino acid responses in relay neurons of the rat lateral geniculate nucleus.
Harata N; Katayama J; Akaike N
Neuroscience; 1999 Mar; 89(1):109-25. PubMed ID: 10051221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
